九洲药业投?200万美元在日本CRO服务q_
作者：yuanxc 来源Q互联网 点击敎ͼ0 更新旉Q?024-2-2 15:26:34
相关q接
The industrial chain effect of macrolide APIs is prominent
仙琚制药拟参投创新药企业w`医药
q大医药投资多普泰医药科技 加码心脑血疾病治疗赛?/a>
千金药业?000万投资甾体药物全产业链企业新合新
Reasons for the sales growth of macrolides in Guo Bang Pharmaceutical in the first half of 2023
The project of Angel Yeast Binzhou Company with an annual output of 40,000 tons of new yeast products (microbial protein) has been completed put into production.
江九洲药业“卤代S-(全氟烷基)-二苯q噻吩盐及其制备Ҏ”荣获“中国专利优U奖?/a>
Analysis of 70 macrocyclic drugs approved by the FDA
仙琚制药拟参投创新药企业w`医药
q大医药投资多普泰医药科技 加码心脑血疾病治疗赛?/a>
千金药业?000万投资甾体药物全产业链企业新合新
Reasons for the sales growth of macrolides in Guo Bang Pharmaceutical in the first half of 2023
The project of Angel Yeast Binzhou Company with an annual output of 40,000 tons of new yeast products (microbial protein) has been completed put into production.
江九洲药业“卤代S-(全氟烷基)-二苯q噻吩盐及其制备Ҏ”荣获“中国专利优U奖?/a>
Analysis of 70 macrocyclic drugs approved by the FDA